Moderna boosts supply agreements with Covax, Gavi by 20 million doses this year and 20 million doses next yearMarket Watch • 12/10/21
Moderna Announces Additional 20 Million Doses of COVID-19 Vaccine to COVAX for Supply in 2021 and New Additional Supply Agreement for 2022Business Wire • 12/10/21
Moderna's flu vaccine candidate shows positive interim results in Phase 1 studyMarket Watch • 12/10/21
Moderna Announces Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program UpdateBusiness Wire • 12/10/21
Moderna to Host Conference Call on Phase 1 Interim Analysis for mRNA Flu Vaccine on Friday, December 10Business Wire • 12/09/21
Mix & Match Pfizer, AstraZeneca COVID-19 Vaccine With Moderna Shows Improved Immune ResponseBenzinga • 12/07/21
Moderna, BioNTech plunge as Bernie Sanders slams 'obscene' profits and tells drug makers to share COVID-19 vaccines with the worldBusiness Insider • 12/06/21
Moderna's President Hoge Sees 'Reboot' Of Existing Shots If Efficacy Falls 50%: BloombergBenzinga • 12/06/21
Could Moderna and AstraZeneca's mRNA Heart Failure Drug Candidate Be a Winner?The Motley Fool • 12/04/21